Fit-for-purpose analytical development for an emerging cell therapy landscape

Thursday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST

Sponsor

Fit-for-purpose analytical development for an emerging cell therapy landscape

Cutting-edge processing and engineering approaches across diverse therapeutic modalities are continually reshaping the landscape of cell therapy. From discovery through to clinical application and manufacturing, the cell therapy sector is broadening its horizons and redefining what is possible.

In this discussion, key opinion leaders representing biopharmas working with varying cell types will pool their expertise to tackle current development challenges, assess the impact of regulatory changes, and predict potential future directions for novel therapies approaching the clinic.

The panel will also deep-dive into the specific considerations and opportunities presented by the latest analytical tool innovations, creating a blueprint for streamlined, robust cell therapy characterization and QC for this expanding field.

Gain insight into cutting-edge innovation in cell therapy: Find out about the latest advancements and technologies driving the field of cell therapy forward, from emerging target indications to novel cellular engineering techniques and manufacturing processes
Overcome analytical development challenges: Learn from experts about common barriers faced across cell therapy product development, as well as more specific issues encountered for particular cell types and therapeutic modalities. Explore practical methods and solutions towards addressing each type of obstacle
Inform your future analytical development strategy: Build your understanding of emerging analytical tool and platform capabilities, and their applicability to cell therapy

Jie Wei

Director, Bioanalytical Sciences at Tr1x Inc.

Dr. Jie Wei is a leading expert in analytical development for cell therapies, with extensive experience in advancing next-generation cell therapy modalities. With a strong foundation in molecular biology and biopharmaceutical development, Dr. Wei has played a pivotal role in designing and implementing robust analytical strategies to support the characterization, potency and quality control of cell therapy. Her expertise spans assay development, regulatory compliance, and CMC strategy, ensuring analytical methods align with evolving industry standards development, driving innovation to enhance the safety, efficacy, and manufacturability of next-generation cell therapies.

Damian Marshall

VP Analytical Development at Resolution Therapeutics

Dr. Damian Marshall is the Vice President of Analytical Development at Resolution Therapeutics, bringing over 20 years of experience in the cell and gene therapy field. Since joining the company in 2022, he has led a team dedicated to advancing the clinical development of mRNA-engineered macrophage therapies for the treatment of inflammatory and fibrotic diseases.

Prior to his current role, Damian served as Vice President of Manufacturing Science and Technology at Achilles Therapeutics, supporting the development of T cell therapies for the treatment of solid tumours. He has also held leadership positions at the Cell and Gene Therapy Catapult, including Director of New Technologies and Head of Analytical Development. Earlier in his career, he was the Head of Cell Biology R&D at LGC Ltd and a Senior Scientist at Intercytex Ltd, an pioneering cell therapy company based in Manchester UK.

Florian Durst

Manager, Application Scientists, BioProduction Group at Thermo Fisher Scientific

Florian Durst is the Manager of Field Application Scientists for EMEA at Thermo Fisher Scientific. With a background in biochemistry and biophysical chemistry, including structural and molecular biology, he leads a team of FAS professionals dedicated to supporting customers in adopting and optimizing cutting-edge technologies.

Passionate about enabling scientific innovation, Florian and his team collaborate closely with researchers and industry partners, providing expert guidance on emerging technologies and their applications. Their goal is to help customers navigate complex workflows, streamline processes, and maximize the impact of their research.